EUROFINS SCIENTIFIC (ESF0.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ESF0 - FR0014000MR3 - Common Stock
60 EUR
+2.16 (+3.73%)
Taking everything into account, ESF0 scores 6 out of 10 in our fundamental rating. ESF0 was compared to 22 industry peers in the Life Sciences Tools & Services industry. Both the profitability and the financial health of ESF0 get a neutral evaluation. Nothing too spectacular is happening here. ESF0 is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make ESF0 a good candidate for value investing.
1. Profitability
1.1 Basic Checks
In the past year ESF0 was profitable.
In the past year ESF0 had a positive cash flow from operations.
In the past 5 years ESF0 has always been profitable.
In the past 5 years ESF0 always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of ESF0 (3.54%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 8.09%, ESF0 is in line with its industry, outperforming 59.09% of the companies in the same industry.
With a decent Return On Invested Capital value of 9.79%, ESF0 is doing good in the industry, outperforming 72.73% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ESF0 is in line with the industry average of 9.42%.
The last Return On Invested Capital (9.79%) for ESF0 is above the 3 year average (8.70%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 8.09% | ||
| ROIC | 9.79% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
1.3 Margins
ESF0's Profit Margin of 5.44% is on the low side compared to the rest of the industry. ESF0 is outperformed by 63.64% of its industry peers.
In the last couple of years the Profit Margin of ESF0 has grown nicely.
ESF0's Operating Margin of 15.59% is in line compared to the rest of the industry. ESF0 outperforms 50.00% of its industry peers.
ESF0's Operating Margin has improved in the last couple of years.
ESF0 has a worse Gross Margin (23.29%) than 86.36% of its industry peers.
In the last couple of years the Gross Margin of ESF0 has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.59% | ||
| PM (TTM) | 5.44% | ||
| GM | 23.29% |
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ESF0 is creating some value.
ESF0 has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ESF0 has been increased compared to 5 years ago.
Compared to 1 year ago, ESF0 has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.66 indicates that ESF0 is not a great score, but indicates only limited risk for bankruptcy at the moment.
ESF0's Altman-Z score of 2.66 is in line compared to the rest of the industry. ESF0 outperforms 50.00% of its industry peers.
ESF0 has a debt to FCF ratio of 5.25. This is a neutral value as ESF0 would need 5.25 years to pay back of all of its debts.
ESF0 has a Debt to FCF ratio (5.25) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.77 indicates that ESF0 is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.77, ESF0 is doing worse than 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 5.25 | ||
| Altman-Z | 2.66 |
ROIC/WACC1.15
WACC8.48%
2.3 Liquidity
ESF0 has a Current Ratio of 1.26. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
ESF0's Current ratio of 1.26 is in line compared to the rest of the industry. ESF0 outperforms 40.91% of its industry peers.
ESF0 has a Quick Ratio of 1.19. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
ESF0 has a Quick ratio of 1.19. This is amongst the best in the industry. ESF0 outperforms 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.50% over the past year.
Measured over the past years, ESF0 shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.34% on average per year.
Looking at the last year, ESF0 shows a small growth in Revenue. The Revenue has grown by 2.53% in the last year.
ESF0 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.78% yearly.
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
3.2 Future
Based on estimates for the next years, ESF0 will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.60% on average per year.
The Revenue is expected to grow by 7.38% on average over the next years.
EPS Next Y14.43%
EPS Next 2Y13.37%
EPS Next 3Y13.84%
EPS Next 5Y15.6%
Revenue Next Year5.07%
Revenue Next 2Y5.39%
Revenue Next 3Y5.87%
Revenue Next 5Y7.38%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 16.67, which indicates a correct valuation of ESF0.
Based on the Price/Earnings ratio, ESF0 is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of ESF0 to the average of the S&P500 Index (26.22), we can say ESF0 is valued slightly cheaper.
The Price/Forward Earnings ratio is 15.11, which indicates a correct valuation of ESF0.
77.27% of the companies in the same industry are more expensive than ESF0, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ESF0 to the average of the S&P500 Index (23.58), we can say ESF0 is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.67 | ||
| Fwd PE | 15.11 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ESF0 is valued cheaper than 86.36% of the companies in the same industry.
90.91% of the companies in the same industry are more expensive than ESF0, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.94 | ||
| EV/EBITDA | 8.41 |
4.3 Compensation for Growth
ESF0's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ESF0 may justify a higher PE ratio.
A more expensive valuation may be justified as ESF0's earnings are expected to grow with 13.84% in the coming years.
PEG (NY)1.15
PEG (5Y)0.91
EPS Next 2Y13.37%
EPS Next 3Y13.84%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.04%, ESF0 has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 0.57, ESF0 pays a better dividend. On top of this ESF0 pays more dividend than 81.82% of the companies listed in the same industry.
With a Dividend Yield of 1.04, ESF0 pays less dividend than the S&P500 average, which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.04% |
5.2 History
The dividend of ESF0 is nicely growing with an annual growth rate of 16.51%!
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
ESF0 pays out 54.91% of its income as dividend. This is a bit on the high side, but may be sustainable.
ESF0's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP54.91%
EPS Next 2Y13.37%
EPS Next 3Y13.84%
FRA:ESF0 (12/16/2025, 7:00:00 PM)
60
+2.16 (+3.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners36.14%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap10.93B
Revenue(TTM)6.89B
Net Income(TTM)374.80M
Analysts69.47
Price Target65.82 (9.7%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.04% |
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP54.91%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.98%
PT rev (3m)1.46%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.19%
EPS NY rev (3m)0.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.6%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.67 | ||
| Fwd PE | 15.11 | ||
| P/S | 1.59 | ||
| P/FCF | 13.94 | ||
| P/OCF | 8.31 | ||
| P/B | 2.36 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.41 |
EPS(TTM)3.6
EY6%
EPS(NY)3.97
Fwd EY6.62%
FCF(TTM)4.3
FCFY7.17%
OCF(TTM)7.22
OCFY12.03%
SpS37.84
BVpS25.45
TBVpS-3.69
PEG (NY)1.15
PEG (5Y)0.91
Graham Number45.4
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 8.09% | ||
| ROCE | 12.64% | ||
| ROIC | 9.79% | ||
| ROICexc | 10.74% | ||
| ROICexgc | 34.1% | ||
| OM | 15.59% | ||
| PM (TTM) | 5.44% | ||
| GM | 23.29% | ||
| FCFM | 11.37% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ROICexc(3y)9.52%
ROICexc(5y)11.6%
ROICexgc(3y)31.02%
ROICexgc(5y)39.55%
ROCE(3y)11.31%
ROCE(5y)13.7%
ROICexgc growth 3Y-18.17%
ROICexgc growth 5Y3.78%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y6.63%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
F-Score7
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 5.25 | ||
| Debt/EBITDA | 2.1 | ||
| Cap/Depr | 84.94% | ||
| Cap/Sales | 7.7% | ||
| Interest Coverage | 9.93 | ||
| Cash Conversion | 77.37% | ||
| Profit Quality | 209.21% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 2.66 |
F-Score7
WACC8.48%
ROIC/WACC1.15
Cap/Depr(3y)89.21%
Cap/Depr(5y)85.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)7.99%
Profit Quality(3y)162.79%
Profit Quality(5y)158.88%
High Growth Momentum
Growth
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
EPS Next Y14.43%
EPS Next 2Y13.37%
EPS Next 3Y13.84%
EPS Next 5Y15.6%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
Revenue Next Year5.07%
Revenue Next 2Y5.39%
Revenue Next 3Y5.87%
Revenue Next 5Y7.38%
EBIT growth 1Y14.03%
EBIT growth 3Y-10.93%
EBIT growth 5Y12.66%
EBIT Next Year83.84%
EBIT Next 3Y29.85%
EBIT Next 5Y22.43%
FCF growth 1Y113.13%
FCF growth 3Y-7.69%
FCF growth 5Y25.62%
OCF growth 1Y31.31%
OCF growth 3Y-4.44%
OCF growth 5Y14.24%
EUROFINS SCIENTIFIC / ESF0.DE FAQ
Can you provide the ChartMill fundamental rating for EUROFINS SCIENTIFIC?
ChartMill assigns a fundamental rating of 6 / 10 to ESF0.DE.
Can you provide the valuation status for EUROFINS SCIENTIFIC?
ChartMill assigns a valuation rating of 7 / 10 to EUROFINS SCIENTIFIC (ESF0.DE). This can be considered as Undervalued.
What is the profitability of ESF0 stock?
EUROFINS SCIENTIFIC (ESF0.DE) has a profitability rating of 6 / 10.
Can you provide the expected EPS growth for ESF0 stock?
The Earnings per Share (EPS) of EUROFINS SCIENTIFIC (ESF0.DE) is expected to grow by 14.43% in the next year.
Can you provide the dividend sustainability for ESF0 stock?
The dividend rating of EUROFINS SCIENTIFIC (ESF0.DE) is 4 / 10 and the dividend payout ratio is 54.91%.